Tacedinaline is a histone deacetylase (HDAC) inhibitor and substituted benzamide derivative that has been investigated as a therapeutic candidate for various oncological conditions and, more recently,… Read more
Tacedinaline is a histone deacetylase (HDAC) inhibitor and substituted benzamide derivative that has been investigated as a therapeutic candidate for various oncological conditions and, more recently, for the treatment of neurodegenerative diseases. This category features a comprehensive selection of high-quality reference standards essential for the rigorous characterization of this compound. Pharmaceutical and research laboratories utilize these Tacedinaline API standards, along with their associated impurities and metabolites, to support critical stages of drug development. These materials are fundamental for precise impurity profiling and the development of robust analytical methods. Furthermore, the inclusion of stable isotope labelled compounds provides the necessary internal standards for accurate quantification and validation during complex analytical testing and quality control procedures, ensuring consistency and regulatory compliance throughout the lifecycle of the pharmaceutical product.